Company Filing History:
Years Active: 2009-2018
Title: Natalya Alexandrovna Ponomarenko: Innovator in Medical Research
Introduction
Natalya Alexandrovna Ponomarenko is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of medical research, particularly in the treatment of autoimmune diseases such as multiple sclerosis. With a total of 2 patents, her work focuses on innovative therapeutic approaches that aim to improve patient outcomes.
Latest Patents
Ponomarenko's latest patents include a composition for the treatment of multiple sclerosis, which involves novel oligopeptides. These oligopeptides are homologous in amino acid sequence to selected parts of the human myelin basic protein (MBP). They are designed to ameliorate the progression of multiple sclerosis by binding to and inactivating epitope-specific anti-MBP catalytic autoantibodies involved in the degradation of MBP. Another significant patent is a method for producing catalytic antibodies and antigens for immunization. This method allows for the creation of a catalytic vaccine that exhibits adhesive properties to antigens while also performing a destructive function, thereby suspending the progression of disease.
Career Highlights
Throughout her career, Ponomarenko has worked with notable companies such as FDS Pharma and Lifebio Laboratories LLC. Her experience in these organizations has allowed her to develop and refine her innovative approaches to medical treatments.
Collaborations
Ponomarenko has collaborated with esteemed colleagues, including Alexandr Gabibovich Gabibov and Alexandr Vladimirovich Kolesnikov. These partnerships have contributed to her research and the advancement of her patented technologies.
Conclusion
Natalya Alexandrovna Ponomarenko is a trailblazer in the field of medical research, with her innovative patents paving the way for new treatments for multiple sclerosis. Her dedication to improving patient care through scientific advancements is commendable.